Kristen Kluska
Stock Analyst at Cantor Fitzgerald
(4.84)
# 407
Out of 4,455 analysts
367
Total ratings
49.4%
Success rate
25.5%
Average return
Main Sectors:
Stocks Rated by Kristen Kluska
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics | Maintained: Buy | $11 | $4.39 | +150.57% | 5 | Jun 25, 2026 | |
| STO: EGTX Egetis Therapeutics AB (publ) | Initiated Coverage: Buy | kr 23.00 | $5.63 | +308.53% | 1 | Jun 25, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Maintained: Buy | $27.05 | $9.38 | +188.39% | 9 | Jun 24, 2026 | |
| RNA Atrium Therapeutics | Initiated Coverage: Buy | $25 | $13.19 | +89.54% | 1 | Jun 18, 2026 | |
| QURE uniQure | Upgraded: Buy | n/a | $47.51 | - | 12 | Jun 17, 2026 | |
| CDXS Codexis | Maintained: Buy | $11 | $2.39 | +360.25% | 10 | Jun 16, 2026 | |
| CLDX Celldex Therapeutics | Maintained: Buy | $67 | $35.26 | +90.02% | 25 | Jun 14, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | $24 → $34 | $13.52 | +151.48% | 9 | Jun 8, 2026 | |
| RARE Ultragenyx Pharmaceutical | Rated: Buy | $84 → $96 | $30.77 | +211.99% | 15 | May 20, 2026 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $109 | $87.68 | +24.32% | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $26.44 | +134.49% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $9.29 | +72.23% | 2 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.2966 | +911.46% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $74.78 | +67.16% | 17 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $9 → $3.16 | $3.17 | -0.32% | 6 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $16.01 | +199.81% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $9.42 | +69.85% | 9 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $124 | $84.43 | +46.87% | 22 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $4.75 | +300.00% | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 | $8.75 | +242.86% | 12 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $6.34 | +199.68% | 19 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $24 | $3.80 | +531.58% | 8 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $21 | $16.85 | +24.63% | 27 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $0.6799 | +194.16% | 9 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 | $38.69 | -1.78% | 13 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 | $46.84 | +34.50% | 9 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $5.61 | +399.11% | 11 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $10.72 | +170.52% | 7 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $4.02 | +248.26% | 8 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $0.7086 | n/a | 4 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $4.00 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.28 | n/a | 3 | Feb 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $20 | $1.71 | n/a | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $10.88 | n/a | 3 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $0.99 | n/a | 3 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $25.36 | n/a | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.59 | n/a | 2 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 → $28 | $0.054 | n/a | 2 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $20 | $0.000001 | n/a | 3 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.3956 | n/a | 4 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.25 → $10 | $1.67 | n/a | 3 | Dec 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $11 | $0.5735 | n/a | 2 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $6.97 | n/a | 1 | Dec 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $1.50 | n/a | 6 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.7033 | n/a | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $0.0056 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $0.3889 | n/a | 1 | Nov 30, 2020 |
Aquestive Therapeutics
Jun 25, 2026
Maintained: Buy
Price Target: $11
Current: $4.39
Upside: +150.57%
Egetis Therapeutics AB (publ)
Jun 25, 2026
Initiated Coverage: Buy
Price Target: kr 23.00
Current: $5.63
Upside: +308.53%
Eupraxia Pharmaceuticals Inc.
Jun 24, 2026
Maintained: Buy
Price Target: $27.05
Current: $9.38
Upside: +188.39%
Atrium Therapeutics
Jun 18, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $13.19
Upside: +89.54%
uniQure
Jun 17, 2026
Upgraded: Buy
Price Target: n/a
Current: $47.51
Upside: -
Codexis
Jun 16, 2026
Maintained: Buy
Price Target: $11
Current: $2.39
Upside: +360.25%
Celldex Therapeutics
Jun 14, 2026
Maintained: Buy
Price Target: $67
Current: $35.26
Upside: +90.02%
Zevra Therapeutics
Jun 8, 2026
Maintained: Buy
Price Target: $24 → $34
Current: $13.52
Upside: +151.48%
Ultragenyx Pharmaceutical
May 20, 2026
Rated: Buy
Price Target: $84 → $96
Current: $30.77
Upside: +211.99%
Monopar Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $109
Current: $87.68
Upside: +24.32%
May 12, 2026
Maintained: Buy
Price Target: $62
Current: $26.44
Upside: +134.49%
May 12, 2026
Maintained: Buy
Price Target: $16
Current: $9.29
Upside: +72.23%
May 12, 2026
Maintained: Buy
Price Target: $3
Current: $0.2966
Upside: +911.46%
May 12, 2026
Maintained: Buy
Price Target: $125
Current: $74.78
Upside: +67.16%
May 1, 2026
Downgraded: Hold
Price Target: $9 → $3.16
Current: $3.17
Upside: -0.32%
Apr 30, 2026
Maintained: Buy
Price Target: $48
Current: $16.01
Upside: +199.81%
Apr 30, 2026
Maintained: Buy
Price Target: $16
Current: $9.42
Upside: +69.85%
Apr 28, 2026
Maintained: Buy
Price Target: $124
Current: $84.43
Upside: +46.87%
Mar 30, 2026
Maintained: Buy
Price Target: $19
Current: $4.75
Upside: +300.00%
Mar 25, 2026
Downgraded: Hold
Price Target: $30
Current: $8.75
Upside: +242.86%
Mar 24, 2026
Maintained: Buy
Price Target: $19
Current: $6.34
Upside: +199.68%
Mar 19, 2026
Maintained: Buy
Price Target: $15 → $24
Current: $3.80
Upside: +531.58%
Mar 16, 2026
Maintained: Hold
Price Target: $14 → $21
Current: $16.85
Upside: +24.63%
Mar 10, 2026
Maintained: Hold
Price Target: $2
Current: $0.6799
Upside: +194.16%
Mar 3, 2026
Maintained: Hold
Price Target: $38
Current: $38.69
Upside: -1.78%
Feb 24, 2026
Maintained: Buy
Price Target: $63
Current: $46.84
Upside: +34.50%
Feb 23, 2026
Maintained: Buy
Price Target: $28
Current: $5.61
Upside: +399.11%
Jan 13, 2026
Maintained: Buy
Price Target: $29
Current: $10.72
Upside: +170.52%
Nov 21, 2025
Maintained: Buy
Price Target: $14
Current: $4.02
Upside: +248.26%
Jul 1, 2024
Maintained: Buy
Price Target: $6 → $7
Current: $0.7086
Upside: n/a
May 13, 2024
Rated: Buy
Price Target: n/a
Current: $4.00
Upside: n/a
Feb 4, 2024
Maintained: Buy
Price Target: $6
Current: $1.28
Upside: n/a
Aug 30, 2023
Downgraded: Hold
Price Target: $4 → $20
Current: $1.71
Upside: n/a
Aug 28, 2023
Reiterated: Buy
Price Target: $23
Current: $10.88
Upside: n/a
Jun 28, 2023
Maintained: Buy
Price Target: $27
Current: $0.99
Upside: n/a
Jun 26, 2023
Reiterated: Buy
Price Target: $17
Current: $25.36
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $1.59
Upside: n/a
May 15, 2023
Maintained: Buy
Price Target: $3.5 → $28
Current: $0.054
Upside: n/a
Mar 16, 2023
Downgraded: Hold
Price Target: $28 → $20
Current: $0.000001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.3956
Upside: n/a
Dec 21, 2022
Maintained: Hold
Price Target: $4.25 → $10
Current: $1.67
Upside: n/a
Aug 4, 2022
Downgraded: Hold
Price Target: $14 → $11
Current: $0.5735
Upside: n/a
Dec 29, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $6.97
Upside: n/a
Sep 28, 2021
Reiterated: Hold
Price Target: $4
Current: $1.50
Upside: n/a
May 12, 2021
Maintained: Buy
Price Target: $10
Current: $0.7033
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $22
Current: $0.0056
Upside: n/a
Nov 30, 2020
Initiated Coverage: Buy
Price Target: $9
Current: $0.3889
Upside: n/a